[Immune tolerance and antilymphocyte sera].
D000818:Animals; D000921:Antibody-Producing Cells; D000941:Antigens / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000494:pharmacology / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D001787:Blood Group Incompatibility; D000882:Haplorhini; D016027:Heart Transplantation; D006386:Hemagglutination Tests; D006650:Histocompatibility Testing; D006801:Humans; D006968:Hypersensitivity, Delayed; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008231:Lymphopenia / Q000139:chemically induced; D051379:Mice; D009369:Neoplasms / Q000209:etiology; D010587:Phagocytosis; D013921:Thrombocytopenia / Q000139:chemically induced; D014180:Transplantation / Q000009:adverse effects; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000941:Antigens; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents
Immunotoleranz und Antilymphozytenseren.